About: Gating of auditory P50 in schizophrenics: unique effects of clozapine

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Gating of auditory P50 in schizophrenics: unique effects of clozapine Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 August 1996

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 1996 (uk) im August 1996 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'agostu de 1996 (ast) scientific article published on 01 August 1996 (en)
publication date	wds:Q71589321-3C464BC7-17F2-4C37-A202-CDCBDEA953FB
publication date	1996-08-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q71589321-313F8594-0AA7-4D6C-8790-840A067F7744 wds:Q71589321-867AA320-ACB6-4D7F-A7DD-9B4B6801F7D5 wds:Q71589321-8E734F52-0D8D-412C-AE5D-E07B3EAB1550 wds:Q71589321-9D0721AF-5F4A-4CAA-8096-606CD7E02487 wds:Q71589321-E316CE9C-8B5F-4BBC-A9EC-3FCB864D2EA1 wds:Q71589321-EBE4143F-CB84-4C42-AEFD-D39C65C839D5
author name string	Freedman R Adler LE Nagamoto HT Griffith JM Hea RA McRae KA
rdfs:label	Gating of auditory P50 in schizophrenics: unique effects of clozapine (en) Gating of auditory P50 in schizophrenics: unique effects of clozapine (nl)
skos:prefLabel	Gating of auditory P50 in schizophrenics: unique effects of clozapine (en) Gating of auditory P50 in schizophrenics: unique effects of clozapine (nl)
name	Gating of auditory P50 in schizophrenics: unique effects of clozapine (en) Gating of auditory P50 in schizophrenics: unique effects of clozapine (nl)
title	wds:Q71589321-11751CBF-D6DA-4425-B256-CB917C467CAF
title	Gating of auditory P50 in schizophrenics: unique effects of clozapine (en)
page(s)	wds:Q71589321-50CC201E-B7F9-4457-BA90-9680D70D2187
page(s)	181-188
instance of	wds:Q71589321-CD1960F5-D070-4604-B295-680C83DB445A
instance of	scholarly article
main subject	wds:Q71589321-9D5A6F51-0EF3-4455-84C8-BD62EBD67291
main subject	schizophrenia
PubMed ID	wds:Q71589321-CC95590F-7445-45FA-B6F1-BD2B02B88E20
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8830951
PubMed ID	8830951
published in	wds:Q71589321-50058D7B-A052-4130-A463-3089CE831003
published in	Biological Psychiatry
issue	wds:Q71589321-082976FA-B316-4928-80F0-C2AA536AB352
volume	wds:Q71589321-B7CB5FEF-FEEB-4290-AA4A-D3EFD4ACA0E6
issue	3
volume	40
DOI	wds:Q71589321-AEE0B484-AC6C-468A-B746-1F8692E18DCC
DOI	http://dx.doi.org/10.1016/0006-3223(95)00371-1
DOI	10.1016/0006-3223(95)00371-1
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71589321
is cites work of	Smoking, Genetics and Schizophrenia: Evidence for Self Medication Smoking and therapeutic response to clozapine in patients with schizophrenia Generators of the intracranial P50 response in auditory sensory gating Modulating sensory gating in healthy volunteers: the effects of ketamine and haloperidol Response to the first stimulus determines reduced auditory evoked response suppression in schizophrenia: single trials analysis using MEG. The P50 auditory event-evoked potential in adult attention-deficit disorder: comparison with schizophrenia Intragastric DMXB-A, an alpha7 nicotinic agonist, improves deficient sensory inhibition in DBA/2 mice Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus The use of neurophysiological endophenotypes to understand the genetic basis of schizophrenia. Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures Human and animal studies of schizophrenia-related gating deficits Haplotype transmission disequilibrium and evidence for linkage of the CHRNA7 gene region to schizophrenia in Southern African Bantu families Elementary phenotypes in the neurobiological and genetic study of schizophrenia Auditory sensory gating in hippocampus and reticular thalamic neurons in anesthetized rats Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels. P50 suppression and its neural generators in antipsychotic-naive first-episode schizophrenia before and after 6 months of quetiapine treatment The effects of increased serotonergic activity on human sensory gating and its neural generators. Evidence for a frontal cortex role in both auditory and somatosensory habituation: a MEG study Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder Smoking and schizophrenia: abnormal nicotinic receptor expression Nicotinic systems in central nervous systems disease: degenerative disorders and beyond The genetics of sensory gating deficits in schizophrenia Smoking and mental illness The moderating role of the dopamine transporter 1 gene on P50 sensory gating and its modulation by nicotine Characterization of neurophysiologic and neurocognitive biomarkers for use in genomic and clinical outcome studies of schizophrenia Neuronal substrates of sensory gating within the human brain. Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia Amphetamine disrupts P50 suppression in normal subjects Tropisetron improves deficient inhibitory auditory processing in DBA/2 mice: role of alpha 7 nicotinic acetylcholine receptors Do self-reports of perceptual anomalies reflect gating deficits in schizophrenia patients? Vulnerability markers in the schizophrenia spectrum: implications for phenomenology, genetics, and the identification of the schizophrenia prodrome Effects of acute and chronic clozapine on D-amphetamine-induced disruption of auditory gating in the rat. P50 sensory gating is related to performance on select tasks of cognitive inhibition Combat veterans with posttraumatic stress disorder exhibit decreased habituation of the P1 midlatency auditory evoked potential Differential effects of acute serotonin and dopamine depletion on prepulse inhibition and p50 suppression measures of sensorimotor and sensory gating in humans. How human electrophysiology informs psychopharmacology: from bottom-up driven processing to top-down control Applications of the P50 evoked response to the evaluation of cognitive impairments after traumatic brain injury Surrogate outcomes in neurology, psychiatry, and psychopharmacology Predictors and markers of clozapine response The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function Cognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking Medications Development for the Treatment of Nicotine Dependence in Individuals with Schizophrenia Concomitant clozapine reduces smoking in patients treated with risperidone Antipsychotic medication and smoking prevalence in acutely hospitalized patients with chronic schizophrenia Olanzapine improves deficient sensory inhibition in DBA/2 mice Why do schizophrenic patients smoke? Endophenotyping schizotypy: a prelude to genetic studies within the schizophrenia spectrum Ondansetron results in improved auditory gating in DBA/2 mice through a cholinergic mechanism Genetic bases for endophenotypes in psychiatric disorders The postimperative negative variation following ambiguous matching of auditory stimuli Translational utility of rodent hippocampal auditory gating in schizophrenia research: a review and evaluation Pharmacokinetic Limitations on Effects of an Alpha7 Nicotinic Receptor Agonist in Schizophrenia: Randomized Trial with an Extended Release Formulation Input dysfunction, schizotypy, and genetic models of schizophrenia.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software